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GABAA receptors mediate a large fraction of inhibitory neurotransmission in the
central nervous system. Two major classes of GABAA receptors are γ2-containing
receptors and δ-containing receptors, which are largely located synaptically and
extrasynaptically, respectively. Neuroactive steroids such as allopregnanolone (3α5αP)
and allotetrahydrodeoxycorticosterone (THDOC) are hypothesized to selectively affect
δ-containing receptors over γ2-containing receptors. However, the selectivity of
neurosteroids on GABAA receptor classes is controversial. In this study, we re-examined
this issue using mice with picrotoxin resistance associated with either the δ or γ2
subunit. Our results show that 3α5αP potentiated phasic inhibition of GABAA receptors,
and this is mainly through γ2-containing receptors. 3α5αP, with or without exogenous
GABA, potentiated tonic inhibition through GABAA receptors. Surprisingly, potentiation
arose from both γ2- and δ-containing receptors, even when a δ selective agonist THIP
was used to activate current. Although ethanol has been proposed to act through
neurosteroids and to act selectively at δ receptors, we found no evidence for ethanol
potentiation of GABAA receptor function at 50 mM under our experimental conditions.
Finally, we found that the actions of pentobarbital exhibited very similar effects on tonic
current as 3α5αP, emphasizing the broad spectrum nature of neurosteroid potentiation.
Overall, using chemogenetic analysis, our evidence suggests that in a cell population
enriched for δ-containing receptors, neurosteroids act through both δ-containing and
non-δ-containing receptors.
Keywords: hippocampus, GABAA receptor, neurosteroid, allopregnanolone (3α5αP), phasic inhibition, tonic
inhibition
INTRODUCTION
GABAA receptors are ligand-gated, chloride-permeable ion channels mediating inhibitory
neuronal transmission. They play essential roles in regulating neuronal activity and behavior (Sigel
and Steinmann, 2012; Lee and Maguire, 2014). As heteromeric pentamers (Pirker et al., 2000),
they are sometimes divided into two major classes: synaptically located γ2-containing receptors
(γ2 receptors) and extrasynaptically located δ-containing receptors (δ receptors) (Wei et al.,
2003). Developing subunit-selective drugs is a major goal of the pharmaceutical industry (Möhler,
2006, 2011); specifically δ selective drugs may have important applications in neuropsychiatry
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(Orser, 2006). For instance, neurosteroids have recently
generated enthusiasm as antidepressants (Kanes et al., 2017;
Gunduz-Bruce et al., 2019). Their psychoactive profile could
result from selective effects on δ GABAA receptors (Spigelman
et al., 2003; Stell et al., 2003; Carver and Reddy, 2016), but
some studies suggest limited selectivity (Shu et al., 2012). Here
we reinvestigate neurosteroid subunit selectivity in native
receptors with new tools in a well-studied class of δ-subunit
expressing neurons.
Neurosteroids are one example of a wide variety of clinically
important positive allosteric modulators of GABAA receptors.
Other positive modulators include benzodiazepines, barbiturates,
and ethanol (Olsen et al., 2007; Olsen, 2018; Reddy, 2018;
Masiulis et al., 2019). Ethanol and neurosteroids are proposed
to share δ selectivity (Wallner et al., 2003; Wei et al., 2004;
Olsen et al., 2007). In fact, ethanol’s positive effects on δ GABAA
receptor function may be mediated by altered endogenous
neurosteroid production and/or release (Sanna et al., 2004;
Tokuda et al., 2011; Izumi et al., 2015). Benzodiazepines are
dependent on both the specific α subunit and γ subunit
composition of receptors (Pritchett et al., 1989), and barbiturates
are broad spectrum modulators (Olsen, 2018).
Neurosteroids prolong the GABAA receptor response to
synaptic GABA (IPSCs) and increase tonic GABA current (Stell
et al., 2003). A prevalent view is that γ2 receptors are responsible
for phasic inhibition, and δ receptors (in neurons that express
the δ subunit) are responsible for tonic current, sometimes along
with α5/γ2 receptors (Stell et al., 2003; Glykys et al., 2008;
Brickley and Mody, 2012; Whissell et al., 2015). Previous studies
are equivocal on whether the effects of neurosteroids on IPSCs
are through γ2 or through δ receptors (Spigelman et al., 2003;
Stell et al., 2003). Our own previous work suggests that slow, δ
driven IPSCs are prominent in dentate granule cells (Sun et al.,
2018) and so might explain neurosteroid effects. Tonic current
is thought to arise largely (though not exclusively) from high-
affinity δ receptors in cells that express δ subunits (Stell et al.,
2003; Glykys et al., 2008; Brickley and Mody, 2012; Whissell
et al., 2015), so δ-mediated tonic current also offers a potentially
important substrate for δ-selective neurosteroid actions.
Previous studies employed genetic deletion to test
neurosteroid selectivity (Stell et al., 2003; Glykys et al.,
2008; Carver and Reddy, 2016), in part because of the lack
of pharmacological tools to separate δ receptors from γ2
receptors. Although genetic deletion is typically considered
more definitive than pharmacology, knockouts and knockdowns
have caveats of compensation or other secondary changes that
might affect outcomes (Gunther et al., 1995; Korpi et al., 2002;
Peng et al., 2002). Further, sensitivity is sacrificed without the
ability to measure pharmacological actions on different receptor
populations in the same cell.
We recently revisited the role of δ receptors in phasic and
tonic transmission using a knock-in/chemogenetic approach.
We generated mice with picrotoxin (PTX) resistance associated
with either the γ2 subunit (γ2∗ KI) or δ subunit (δ∗ KI)
FIGURE 1 | Prolongation of sIPSC decay by 3α5αP in hippocampal DGCs. (A) Representative WT average sIPSC waveforms obtained before (black) and in the
presence (red) of 100 nM 3α5αP. (B) WT DGC τw of sIPSC decay under baseline (11.7 ± 0.3 ms) and 3α5αP (15.1 ± 0.5 ms). (C) δ* KI average sIPSC waveforms
obtained before, in the presence of 100 nM 3α5αP. (D) δ* KI DGC τw of sIPSC decay under baseline (11.9 ± 0.4 ms) and 3α5αP (14.3 ± 0.9 ms). (E) γ2* KI average
sIPSC waveforms obtained before, in the presence of 100 nM 3α5αP, and with addition of 50 µM PTX. (F) γ2* KI DGC τw of sIPSC decay under baseline
(6.8 ± 0.6 ms) and 3α5αP (10.4 ± 1.2 ms), and 3α5αP/PTX (11.5 ± 0.9 ms). Paired t test showed that 100 nM 3α5αP significantly increased τw of sIPSC decay in
WT (n = 6, p = 3 × 10−3) and δ* KI (n = 8, p = 0.02). In γ2* KI (n = 7) one-way ANOVA on τw of sIPSC decay showed a drug effect (F (1.3,7.7) = 15.3, p = 4 × 10−3),
with a significant difference between baseline and 3α5αP (Holm-Sidak, p = 0.04), and no change between 3α5αP and PTX (Holm-Sidak, p = 0.2). The τw of sIPSC
decay after PTX was not included in panels (B,D) due to the elimination of most sIPSCs by PTX.
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(Gurley et al., 1995; Sedelnikova et al., 2006). This strategy
confers picrotoxin resistance onto receptors containing only a
single mutated subunit (Gurley et al., 1995; Sun et al., 2018).
Here we employed the new mouse lines to reinvestigate the
selectivity of neurosteroids for the two main classes of GABAA
receptors in DGCs.
Our results showed that 3α5αP potentiated phasic inhibition
by prolonging the decay of sIPSCs through an effect on γ2
receptors. 3α5αP also potentiated GABAA tonic inhibition in
slices from WT and the two knock-in genotypes. Based on
complementary PTX sensitivity in the two mutants, the tonic
current was mediated approximately equally by δ receptors and
γ2 receptors. Furthermore, the potentiation of tonic current by
neurosteroids persisted under conditions of no added agonist,
when co-applied with exogenous GABA, and when co-applied
with the δ-selective exogenous agonist THIP. We conclude that
neurosteroids are not selective for δ receptors and that selectivity
is unlikely to underlie unique psychoactive effects.
MATERIALS AND METHODS
Slice Preparation
Mice from postnatal (P)25 to P32 GABAA receptor δ∗ KI, γ2∗
KI, or WT littermates of both sexes were used (Sun et al.,
2018). Mice were anesthetized with isoflurane and decapitated
according to protocols approved by the Washington University
IACUC. After attaching to a Leica VT1200 specimen holder
with cyanoacrylate, coronal brain slices, 300-µM-thick, were cut
in ice-cold, modified artificial CSF (aCSF; used for slicing in
mM: 87 NaCl, 75 sucrose, 25 glucose, 25 NaHCO3, 2.5 KCl,
1.25 NaH2PO4, equilibrated with 95% oxygen-5% CO2 plus 0.5
CaCl2, 3 MgCl2; 320 mOsm). Slices recovered in choline-based
ACSF (in mM: 92 choline chloride, 25 glucose, 30 NaHCO3, 2.5
KCl, 1.2 NaH2PO4, 20 HEPES, 2 thiourea, 5 Na ascorbate, 3 Na
pyruvate, 2 CaCl2, and 1 MgCl2, equilibrated with 95% oxygen-
5% CO2; 300 mOsm) at 32◦C for 30 min. After recovery, slices
were stored in regular aCSF (in mM: 125 NaCl, 25 glucose, 25
NaHCO3, 2.5 KCl, 1.25 NaH2PO4, equilibrated with 95% oxygen-
5% CO2 plus 2.6 CaCl2, 1.2 MgCl2; 310 mOsm) for at least 1 h at
25◦C before experimental recording. Drugs were obtained from
Thermo Fisher Scientific except where noted.
Whole-Cell Recording
Slices were transferred to a recording chamber with continuous
perfusion (2 ml/min, 32◦C) of oxygenated, regular aCSF. To
measure phasic and tonic inhibition of GABAA receptors,
10 µM NBQX (Tocris Bioscience) and 50 µM D-APV (Tocris
Bioscience) were added in the regular aCSF to inhibit ionotropic
glutamate receptors. To isolate current generated by the
respective δ or γ2 subpopulation of GABAA receptors, we applied
50 µM PTX (Tocris Bioscience) in the appropriate subunit
knock-in tissue.
During somatic, whole-cell recording, hippocampal DGCs
were visualized and identified by IR-DIC microscopy (Nikon
FN1 microscope and Photometrics Prime camera). Borosilicate
glass pipettes (World Precision Instruments, Inc.) with open tip
resistance of 3–7 Mwere used for whole-cell recording. Pipettes
were filled with internal solution containing the following (in
mM): 130 CsCl, 10 HEPES, 5 EGTA, 2 MgATP, 0.5 NAGTP, and
4 QX-314; pH adjusted to 7.3 with CsOH; 290 mOsm). A 5-min
stabilization period was given after the whole-cell configuration
was established, and then cells were recorded with a MultiClamp
700B amplifier (Molecular Devices), Digidata 1550 16-bit A/D
converter, and pClamp 10.4 software (Molecular Devices).
Measurement of Phasic and Tonic
GABAA Receptor Current
Cells were voltage-clamped at −70 mV during whole-cell
recordings. Spontaneous phasic GABAA receptor currents were
measured before/after the application of 3α5αP (100 nM). Tonic
GABAA receptor currents were activated by GABA (5 µM),
THIP (1 µM), and/or 3α5αP (100 nM). In some experiments,
DS2 (Tocris Bioscience) and allotetrahydrodeoxycorticosterone
(THDOC) were used as comparators. PTX was added at
the end to isolate δ∗ KI or γ2∗ KI-mediated GABAA
receptor currents. A 5-min perfusion of each drug was used
to ensure maximal effect. All recordings were acquired in
gap-free mode at 5 kHz, filtered at 2 kHz using an 8-
pole Bessel filter.
Analysis and Statistics
Both phasic and tonic GABAA currents were measured after cells
reached steady state for each condition. sIPSCs and tonic currents
were measured as described previously (Sun et al., 2018). At least
FIGURE 2 | Prolongation of δ sIPSC decay. In the presence of 50 µM PTX δ
sIPSCs were isolated as described (Sun et al., 2018). (A) Scaled sIPSC
waveforms from baseline and in the presence of 100 nM 3α5αP from 15 and
17 events, respectively. (B–D) In δ* KI DGCs (n = 7) decays were prolonged by
100 nM 3α5αP from 18.9 ± 2.3 ms to 26.1 ± 1.8 ms (paired t test, p = 0.01).
Neither sIPSC amplitude (−9.1 ± 0.6 pA vs. −7.7 ± 0.7 pA) nor frequency
(0.08 ± 0.006 Hz vs. 0.14 ± 0.04 Hz) was reliably altered (paired t test,
p = 0.08, 0.2, respectively).
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FIGURE 3 | Potentiation of tonic current by 3α5αP alone. (A) Effect of 100 nM 3α5αP in a representative DGC from a WT slice. 3α5αP resulted in a tonic current that
was blocked by 50 µM PTX. Note that the sIPSCs were also largely inhibited by PTX, as also shown in Figure 1. (B) Summary of changes in mean current relative to
baseline. 3α5αP increased tonic current to −7.4 ± 1.5 pA, and PTX decreased it to 2.0 ± 2.2 pA. (C) Summary of the standard deviation of current (baseline:
2.9 ± 0.2 pA, 3α5αP: 4.0 ± 0.3 pA, and 3α5αP+PTX: 1.8 ± 0.2 pA). (D) In a subset of neurons, 50 µM gabazine (gbz) was tested and produced no clear further
impact on tonic current beyond the effect of PTX. Inset shows representative current samples. (E) Gbz also produced minimal change in the standard deviation of
the current, indicating that PTX fully inhibited tonic current. (F–J) The same experiment from δ* KI DGCs. 3α5αP increased tonic current from baseline to
−9.6 ± 1.5 pA, and PTX decreased it to −4.6 ± 1.8 pA. Standard deviation of current for baseline, 3α5αP, and 3α5αP+PTX was 2.4 ± 0.3 pA, 3.0 ± 0.3 pA, and
2.4 ± 0.3 pA, respectively. (K–O) Results from γ2* KI animals. 3α5αP increased tonic current from baseline to -12.3 ± 3.4 pA, and PTX decreased it to
−3.3 ± 2.5 pA. Standard deviation of current for baseline, 3α5αP, and 3α5αP+PTX was 2.9 ± 0.3 pA, 3.8 ± 0.5 pA, and 2.8 ± 0.4 pA, respectively. Paired t test
showed significant difference of tonic currents between 3α5αP and PTX in WT (n = 10, p = 9 × 10−4), δ* KI (n = 5, p = 0.01), and γ2* KI (n = 6, p = 0.03). To
compare genotype effects, we examined differences in the SD values prior to and during gabazaine (not directly shown; statistics performed on difference between
connected SD values). An ANOVA between 3α5αP+PTX and 3α5αP+PTX+gabazine showed a genotype effect (F (2.0,14.0) = 4.2, p = 0.03), with both δ*
(0.7 ± 0.3 pA, n = 6) and γ2* (0.9 ± 0.2 pA, n = 5) exhibiting a difference from WT (0.1 ± 0.03 pA, n = 6) (Holm-Sidak, p = 0.05, 0.03, respectively). For panels
sample current traces in this and subsequent figures, some of the largest sIPSCs have been truncated for clarity of depiction of tonic current.
40 events contributed to average sIPSC waveforms. sIPSC decays
were fit to the sum of two exponential functions, extrapolated
to the peak IPSC. Decay time course is reported as a weighted
time constant (τw) (Sun et al., 2018). Tonic GABAA currents
were obtained by subtracting baseline holding currents. A paired
t test or one-way repeated-measures ANOVA was performed
using GraphPad Prism 8 to detect the effects within cells. Specific
analyses are described in the Results. Significance is presented at
the level of *p ≤ 0.05, **0.01, ***0.001, and ****0.0001. Summary
data are presented as mean± SEM.
RESULTS
Potentiation of Phasic Inhibition by
3α5αP
Neurosteroids like 3α5αP and THDOC potentiate phasic
inhibition by prolonging the decay of sIPSCs in hippocampal
DGCs (Stell et al., 2003). Although this effect has previously been
associated with γ2 receptors, neurosteroids at sufficiently
modest concentrations may have selective effects on δ
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receptors (Stell et al., 2003; Carver and Reddy, 2016), which
may participate more prominently in phasic transmission in
DGCs than typically appreciated (Spigelman et al., 2003; Sun
et al., 2018). In WT cells, 100 nM 3α5αP prolonged the weighted
time constant (τw) of sIPSC decay (Figures 1A,B). In δ∗ KI
DGCs, 3α5αP showed a similar prolongation of sIPSC decay
(Figures 1C,D). PTX eliminated most sIPSCs in both WT and
δ∗ KI DGCs (Figures 1A,C). In γ2∗ KI DGCs, 100 nM 3α5αP
also prolonged the τw of sIPSC decay (Figures 1E,F). However,
baseline γ2∗ sIPSC decay was faster than the other genotypes, as
previously reported (Sun et al., 2018). After PTX addition, the
prolongation of sIPSC decay persisted in γ2∗ cells (Figures 1E,F).
Taken together, these results indicate that 3α5αP prolongs the
decay of sIPSCs in DGCs, and this potentiation is mainly through
γ2 receptors. These results also confirm observations of others
(Stell et al., 2003) but are in contrast with results suggesting a
large impact of neuroactive steroids on a δ component of sIPSCs
(Spigelman et al., 2003).
Although the major effect of neurosteroids is on IPSC time
course, we also examined sIPSC frequency and amplitude. There
was a trend toward decreased frequency with 3α5αP addition
in each of the three genotypes: [WT, n = 6: 2.1 ± 0.5 Hz vs.
1.5 ± 0.2 Hz; δ∗, n = 8: 3.8 ± 0.7 Hz vs. 2.8 ± 0.5 Hz; γ2∗,
n = 7: 2.7 ± 0.8 Hz vs. 2.2 ± 0.4 Hz; (F(1.0,18.0) = 6.7, p = 0.02);
2-way ANOVA, with repeated measures for frequency]. This
likely reflects a general suppression of network activity by the
pro-inhibitory neurosteroid. By contrast, there was no consistent
effect of 3α5αP on amplitude of sIPSCs [WT: −38.9 ± 1.4 pA vs.
−32.5 ± 2.0 pA; δ∗: −37.7 ± 2.5 pA vs. −39.9 ± 1.8 pA; γ2∗:
−54.8± 11.9 pA vs.−50.1± 6.0 pA; (F(1.0,18.0) = 0.8, p = 0.4)].
We have previously shown that sIPSCs mediated by δ
receptors are detectable in DGCs, albeit at a low frequency
FIGURE 4 | 3α5αP potentiation of tonic inhibition with exogenous GABA is non-selective. (A) Effects of exogenous GABA (5 µM) in a representative DGC from a WT
slice. GABA generated a current superimposed on ongoing spontaneous phasic sIPSCs. 3α5αP (100 nM) potentiated the GABA response, and 50 µM PTX
abolished both the phasic and tonic currents. (B) Summary of the GABA/3α5αP current in the indicated conditions from cells of WT animals (n = 5). GABA produced
a tonic current of −20.2 ± 6.7 pA, and 3α5αP increased it to −31.0 ± 7.8 pA, while PTX decreased the tonic current to 7.3 ± 5.4 pA. (C,D) The same experiment
from δ* KI DGCs (n = 6). Similar as WT, GABA generated a tonic current of −22.6 ± 5.2 pA. Note that the GABA/3α5αP tonic current was partially blocked by PTX
(from −35.6 ± 9.0 pA to −6.2 ± 2.6 pA), and phasic currents were strongly reduced. (E,F) Same experiment from γ2* KI DGCs (n = 6). Comparable to δ* KI slices,
GABA activated a tonic current of -19.6 ± 4.6 pA. The GABA/3α5αP current was also partially blocked by PTX (from −36.6 ± 8.8 pA to −7.5 ± 2.9 pA), but the
phasic currents were left mostly intact. Dotted line in panels (A,C,E) shows mean initial holding current, which was subtracted for pooled results in panels (B,D,F).
One-way ANOVA on tonic current showed a drug effect in WT (F (1.9,7.4) = 17.0, p = 2 × 10−3), δ* KI (F (1.3,6.4) = 11.3, p = 0.01), and γ2* KI (F (1.4,6.9) = 13.5,
p = 0.02). PTX significantly decreased GABA/3α5αP current in WT (Holm-Sidak, p = 5 × 10−3), δ* KI (Holm-Sidak, p = 0.03), and γ2* KI (Holm-Sidak, p = 0.02).
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compared with γ2-dominated sIPSCs (Sun et al., 2018). In δ∗
slices incubated in 50 µM PTX, we found that 3α5αP similarly
prolonged δ sIPSCs (Figure 2). Because of the small number
of baseline δ sIPSCs detected, the overall impact on phasic
transmission mediated by δ receptors was modest.
Potentiation of Tonic Inhibition by 3α5αP
Alone
Given that neurosteroid effects on IPSCs do not appear to
involve strong δ selectivity, we turned to tonic currents, where
evidence more strongly supports selective δ receptor effects of
neurosteroids. A prevalent view is that δ receptors mediate a
strong tonic component in DGCs. The selectivity hypothesis
predicts that potentiation of tonic inhibition by neurosteroids
is mainly through δ receptors (Stell et al., 2003; Glykys et al.,
2008; Carver and Reddy, 2016). Under similar conditions to
Figure 1, we examined the effect of 3α5αP on tonic current.
3α5αP similarly potentiated a tonic current in all three genotypes
[one-way ANOVA, (F(2.0,18.0) = 1.4, p = 0.3)]. In WT slices, both
3α5αP tonic current and phasic current were completely blocked
by PTX (Figures 3A,B). In both δ∗ KI and γ2∗ KI DGCs, PTX
partially inhibited the 3α5αP tonic current (Figures 3F,G,K,L).
Because the currents observed were very small, and because
holding current may be affected by technical factors over time,
we examined an alternate measure of GABA channel activity.
Channel-mediated currents are characterized by fluctuations
(noise) that result from the stochastic nature of channel opening
and closing (Anderson and Stevens, 1973). At low probabilities
of channel opening, current fluctuations should correlate with
the tonic current (Farrant and Nusser, 2005; Lingle, 2006) As
a simple measure of these current fluctuations, we calculated
the root mean squared noise level (standard deviation after
subtracting the mean current) in each experimental condition.
Figures 3C,H,M show that the results of this analysis parallel
results from measures of the mean current and are arguably more
sensitive than changes in current amplitudes. In a subset of cells,
we also tested the impact of gabazine co-applied following PTX
addition. Results showed trends toward further reduction in the
two mutant phenotypes with no change in WT (Figures 3D,I,N).
FIGURE 5 | 3α5αP potentiates THIP-generated current. (A) Effects of 1 µM THIP plus 10 µM DS2 in a representative DGC from a δ* KI slice. DS2 potentiated the
THIP-evoked current, and this current was resistant to 50 µM PTX. (B) Summary of the current in the indicated conditions from cells of δ* KI animals (n = 6). Tonic
current under THIP, THIP+DS2, and THIP+DS2+PTX was −21.9 ± 3.0 pA, −44.1 ± 7.6 pA, and −40.2 ± 9.8 pA, respectively. (C) Effects of THIP/100 nM 3α5αP in
a representative DGC from a δ* KI slice. 3α5αP potentiated the THIP-generated current, but this current was partially blocked by PTX. (D) Summary of the
THIP/3α5αP current in δ* KI DGCs (n = 11). Tonic current under THIP, THIP+3α5αP, and THIP+3α5αP+PTX was -18.4 ± 2.6 pA, −33.2 ± 4.8 pA, and
-13.9 ± 3.9 pA, respectively. (E,F) Same experiment from γ2* KI DGCs (n = 6). Tonic current under THIP, THIP+3α5αP, and THIP+3α5αP+PTX was -19.1 ± 3.1 pA,
−29.3 ± 5.2 pA, and -12.7 ± 2.2 pA, respectively. Note that the GABA/3α5αP current was also partially blocked by PTX, while the phasic currents were mostly left
intact. One-way ANOVA on tonic current showed a drug effect in δ* KI THIP/DS2 (F (1.3,6.4) = 18.5, p = 3 × 10−3), δ* KI THIP/3α5αP (F (2.3,22.7) = 25.1,
p < 1 × 10−4), and γ2* KI THIP/3α5αP (F (1.5,7.4) = 25.7, p = 7 × 10−4). PTX did not change the THIP/DS2 tonic current in δ* KI (Holm-Sidak, p = 0.4), however
PTX significantly decreased THIP/3α5αP generated tonic current in both δ* KI (Holm-Sidak, p = 2 × 10−3), and γ2* KI (Holm-Sidak, p = 7 × 10−3).
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Measures of SD were clearer and showed minimal effect of
gabazine on fluctuations following PTX addition (Figure 3E)
but reduced fluctuations in both δ∗ and γ2∗ backgrounds
(Figures 3J,O). Taken together, the results demonstrate that in
the absence of added agonist, both γ2 and δ receptors contribute
to the effect of 3α5αP on tonic GABA currents.
Potentiation of Tonic Inhibition by 3α5αP
With Exogenous GABA
Perhaps the near absence of ambient GABA, suggested by the
small effect of PTX in WT slices and gabazine in mutant slices
(Figure 3), is not physiological and therefore does not invoke
selectivity that might otherwise be generated by neurosteroids. To
ensure that neurosteroids have the opportunity to interact with
agonist-bound receptors, we applied 5 µM GABA to produce
a tonic current of about 30 pA (Figure 4) (Lee and Maguire,
2014). Note that the actual GABA concentration reaching cells is
likely much lower, as a result of avid GABA transport by neurons
and glia (Nusser and Mody, 2002; Jensen et al., 2003; Zhan
and Nadler, 2009). 100 nM 3α5αP increased the tonic current,
and PTX fully blocked this current (Figures 4A,B). In δ∗ KI
DGCs, GABA/3α5αP produced a current of similar amplitude
to WT that was partially sensitive to PTX (Figures 4C,D).
This suggests that the 3α5αP-potentiated tonic current is only
partially mediated by δ receptors in DGCs and a substantial
fraction is mediated by γ2 receptors. Also, in γ2∗ KI DGCs,
GABA/3α5αP generated a similar amount of tonic current as
WT and δ∗ KI. A one-way ANOVA showed no difference among
genotypes (F(2.0,14.0) = 0.1, p = 0.9). sIPSCs persisted in PTX,
again consistent with γ2 receptors as the main drivers of phasic
inhibition. Interestingly, PTX did not fully block the tonic current
in γ2∗ slices (Figures 4E,F). The complementary results from δ∗
and γ2∗ KI DGCs suggests that 3α5αP potentiates tonic current
arising from both γ2 and δ receptors.
Potentiation of Tonic Inhibition by 3α5αP
and THDOC With Subunit-Selective
Agonist
Surprisingly, our results showed that 3α5αP potentiated both
δ and γ2 receptors to produce/potentiate tonic inhibition. To
determine whether selectivity can be increased by activating
receptors with a low concentration of δ-preferring agonist, we
employed THIP as agonist. Previously, we showed that 1 µM
THIP plus 10 µM DS2 potentiated tonic inhibition in DGCs,
and this drug combination yielded a current mainly through δ
receptors in DGCs (Sun et al., 2018). To evaluate the selectivity of
3α5αP on GABAA receptors when a δ-selective agonist is used, we
co-applied THIP and 3α5αP to KI slices. As a positive control, we
repeated our previous experiment using DS2, a positive allosteric
modulator selective for δ receptors (Jensen et al., 2013). As
expected, in δ∗ KI slices, the tonic current generated by THIP plus
DS2 was resistant to PTX (Figures 5A,B). Although THIP/3α5αP
resulted in a tonic current in δ∗ KI slices comparable in amplitude
to the THIP plus DS2 current, this current was only partially
inhibited by PTX, indicating a contribution from non-δ receptors
(Figures 5C,D). THIP/3α5αP resulted in a similar tonic current
in γ2∗ KI slices. Complementary to the result in δ∗ KI slices, this
current was also partially blocked by PTX (Figures 5E,F).
To probe neurosteroid selectivity further, we employed
another commonly used neurosteroid, THDOC. In WT slices,
THDOC potentiated the THIP-generated tonic current, and this
current was fully blocked by PTX (Figures 6A,B). Similar to
THIP/3α5αP results, in δ∗ KI slices the THIP/THDOC tonic
current was again only partially inhibited by PTX (Figures 6C,D),
indicating the partial contribution of δ receptors to the tonic
inhibition. Taken together, our results show that in contrast to
DS2, either 3α5αP or THDOC co-applied with THIP acts on both
δ and γ2 receptors to potentiate tonic currents.
Lack of Potentiation of Tonic Inhibition
by Ethanol
Ethanol has been shown to potentiate GABAA receptors by
enhancing a tonic current through δ receptors (Wallner et al.,
2003; Wei et al., 2004; Olsen et al., 2007). However, other
studies suggest that ethanol has no effect on GABAA currents,
or that potentiation may simply depend on ambient GABA
concentration (Borghese et al., 2006; Yamashita et al., 2006;
FIGURE 6 | THDOC potentiates THIP-produced current. (A) Effect of 100 nM
THDOC in a representative DGC from a WT slice. THDOC potentiated the
THIP (1 µM) generated current, which was blocked by 50 µM PTX.
(B) Summary of the current in the indicated conditions from WT DGCs (n = 4).
Tonic current under THIP, THIP+THDOC, and THIP+THDOC+PTX was
-19.0 ± 4.4 pA, −29.5 ± 6.1 pA, and 2.5 ± 0.9 pA, respectively. (C,D) Same
experiment from δ* KI DGCs (n = 5). Note that the THIP/THDOC current was
partially blocked by PTX. Tonic current under THIP, THIP+THDOC, and
THIP+THDOC+PTX was -12.6 ± 1.6 pA, −20.2 ± 1.8 pA, and
-10.0 ± 2.1 pA, respectively. One-way ANOVA on tonic current showed a
drug effect in WT (F (1.6,4.8) = 22.9, p = 4 × 10−3), and δ* KI
(F (2.7,10.6) = 42.9, p < 1 × 10−4). PTX significantly decreased THIP/THDOC
tonic current in WT (Holm-Sidak, p = 0.01) and δ* KI (Holm-Sidak,
p = 3 × 10−3).
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Fleming et al., 2011). Thus, it remains unclear and controversial
whether ethanol directly targets GABAA receptors. To investigate
the effects of ethanol on GABAA receptors, we applied 50 mM
ethanol with 5 µM GABA to hippocampal DGCs. Despite
robust GABA-generated currents (Figures 7A–F), ethanol failed
to potentiate the current in any of the three genotypes
(Figures 7B,D,F). Our results show that in contrast to 3α5αP,
ethanol does not target GABAA receptors responsible for GABA-
generated tonic current in DGGs under these conditions.
Potentiation of Tonic Inhibition by
Pentobarbital With Exogenous GABA
We previously found that δ receptors do not contribute
much to the overall current generated by a saturating GABA
concentration and maximum δ receptor current was only 10–
15% that of total current in DGCs (Sun et al., 2018). This
difference in maximum contribution could mask δ receptor
selectivity of neurosteroids. To address this possibility, we tested
the PTX sensitivity of pentobarbital (Pbt), a broad-spectrum
positive allosteric modulator, at a concentration chosen to mimic
100 nM 3α5αP on tonic current in the three genotypes. We
found that 10 µM Pbt produced quantitatively similar sIPSC
prolongation and increased tonic current to a similar degree
as 100 nM 3α5αP (Figures 8A,B). In WT slices, 10 µM Pbt
produced near 30 pA tonic current with exogenous GABA
(Figure 8C), which is comparable to the GABA/3α5αP tonic
current (Figures 4A,B). The GABA/Pbt tonic current was fully
inhibited by PTX (Figure 8C), indicating that the entirety of
the Pbt effect is mediated by GABAA receptors. Importantly, in
δ∗ KI slices, the GABA/Pbt generated tonic current was only
partially blocked by PTX (Figure 8D), to a very similar degree
as 3α5αP potentiated current (Figures 4C,D). Thus, we conclude
that 3α5αP exhibits no more selectivity than the broad spectrum
positive modulator, Pbt at an equivalent concentration.
DISCUSSION
In this study, we used subunits engineered to resist PTX
antagonism to revisit the selectivity of neurosteroids on δ
GABAA receptors in mouse hippocampal DGCs. Our approach
allowed us to measure pharmacological actions on different
receptor populations in the same cell. First, we verified that
3α5αP potentiated phasic inhibition of GABAA receptors
mainly through γ2 receptors, although we recently showed a
δ receptor component to IPSCs (Sun et al., 2018). Second, we
showed that 3α5αP augmented tonic inhibition with or without
exogenous GABA through both δ and γ2 GABAA receptors.
Third, our results showed that even with the subunit-selective
agonist THIP, both 3α5αP and THDOC acted non-selectively
at δ and γ2 receptor populations. Finally, the quantitatively
similar effect of Pbt on PTX-resistant receptors mediating tonic
FIGURE 7 | Lack of potentiation of tonic current by ethanol. (A) Effects of 50 mM ethanol after 5 µM GABA in a representative DGC from a WT slice. GABA
activated a current superimposed on ongoing spontaneous phasic sIPSCs. Ethanol did not potentiate the tonic current. (B) Summary of the GABA/ethanol current in
the indicated conditions from cells of WT animals. Tonic current activated by GABA and GABA+ethanol was −26.8 ± 4.0 pA and −24.2 ± 3.2, respectively. (C,D)
Same experiment from δ* KI animals. Tonic current generated by GABA and GABA+ethanol was −24.3 ± 7.7 pA and −20.3 ± 6.1 pA, respectively. (E,F) Same
experiment from γ2* KI animals. Tonic current produced by GABA and GABA+ethanol was −42.3 ± 7.8 pA and −41.5 ± 6.8 pA, respectively. Paired t test showed
no difference of the tonic currents between GABA and ethanol in WT (n = 6, p = 0.4), δ* KI (n = 3, p = 0.3), and γ2* (n = 4, p = 0.9).
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FIGURE 8 | Pbt potentiates tonic current with exogenous GABA. (A) Replot of
the effect of 100 nM 3α5αP on τw of sIPSCs (from Figure 1B) for comparison
with Pbt effects. (B) 10 µM Pbt increased the τw of sIPSC decay in WT DGCs
from 10.0 ± 0.5 ms to 14.7 ± 0.5 ms (n = 7). (C) Summary of GABA/Pbt
generated current in indicated conditions in WT DGCs (n = 7). Tonic current
under GABA, GABA+Pbt, and GABA+Pbt+50 µM PTX was −20.7 ± 6.2 pA,
−30.7 ± 8.3 pA, and 6.3 ± 2.6 pA, respectively. (D) Summary of GABA/Pbt
generated tonic current in indicated conditions in δ* KI DGCs (n = 7). Tonic
current under GABA, GABA+Pbt, and GABA+Pbt+PTX was −25.3 ± 8.6 pA,
−35.4 ± 9.3 pA, and −4.4 ± 2.4 pA, respectively. Pbt prolonged the decay of
sIPSC (paired t test, p = 1 × 10−3). One-way ANOVA on tonic current
showed a drug effect in WT (F (1.6,4.8) = 22.9, p = 4 × 10−3), and δ* KI
(F (2.7,10.6) = 42.9, p < 1 × 10−4). PTX significantly decreased GABA/Pbt
current in WT (Holm-Sidak, p = 2 × 10−3) and δ* KI (Holm-Sidak, p = 0.01).
current emphasizes the broad spectrum nature of neurosteroid
potentiation. Overall, using a sensitive methodology, our results
revise a prevalent view of neurosteroid selectivity on δ GABAA
receptors and reveal the broad spectrum nature of neurosteroid-
augmented tonic inhibition. Our results indicate that the
psychotropic actions of neurosteroids are unlikely to arise from
selectivity at δ GABAA receptors, although we do not exclude
psychotherapeutic effects via extrasynaptic receptors.
In this study, we used mice with PTX resistance in either
δ or γ2 GABAA receptors. Mice were generated with a knock-
in/chemogenetic approach described in our earlier work (Sun
et al., 2018). The advantage of our approach is that we are able
to investigate the selectivity of neurosteroids within the same
cell, and there is less opportunity than with genetic deletions
for compensation or other secondary effects to influence results.
A caveat is that the γ2 mutation leads to faster IPSCs (Sun et al.,
2018) (Figures 1E,F). Nevertheless, the complementary results
obtained from the two mutant lines help mitigate the possibility
that changes secondary to the T6’Y mutation account for results.
Both mutant mouse lines showed similar response as WT to
GABA and neurosteroid application throughout our experiments
(Figures 3–8). Thus it is unlikely that the non-selectivity of
neurosteroids results from different pharmacological profiles
caused by the mutations. We cannot entirely exclude the
possibility that PTX sensitivity is different in the presence
of neurosteroid compared with agonist alone, and that this
sensitivity changes with the induced mutations. However,
previous results have shown that positive allosteric modulators
gate currents entirely sensitive to PTX (Thompson et al., 1996).
Because the focus of our study was pharmacological actions
of neurosteroids, we did not revisit the receptor source of
endogenous tonic current in the absence of neurosteroid. In fact,
in our hands the DGC standing current is very small (present
study) or undetectable (Sun et al., 2018). In principle, the modest
contribution of δ receptors to 3α5αP potentiation of tonic current
could reflect recruitment of γ2 receptors that are silent in the
presence of ambient GABA alone. Alternatively, the lack of
selectivity could represent amplification of both receptor types
already activated by ambient GABA. Past evidence favors the idea
that γ2 receptors, perhaps those coupled with α5, may mediate
some tonic current in DGCs and other cell types (Glykys et al.,
2008; Kasugai et al., 2010; Patel et al., 2016).
Neurosteroids potentiate the actions of ambient GABA at
low modulator concentration but directly gate the channel at
somewhat higher concentration (Callachan et al., 1987; Cottrell
et al., 1987; Puia et al., 1990; Shu et al., 2004). Because some
cells showed no evidence of measurable ambient GABA current
(Figure 3), we cannot exclude the possibility that direct gating in
the absence of GABA explains current generated by γ2 receptors
in some cells (Shu et al., 2004). As noted above, however, it may
be more likely that 3α5αP increased the effectiveness of very
low concentrations of GABA present, which are ineffective at
baseline. Despite the presence of a non-saturating δ-preferring
THIP concentration in Figure 5, the effect on γ2 appears
to dominate. This seems surprising, as 3α5αP will increase
agonist potency at both receptor classes. The balance of effects
may be explained by the comparatively large number of γ2
receptors. Nevertheless, the discrepancy between the lack of
neurosteroid selectivity and the high degree of DS2 selectivity is
striking (Figure 5).
Our motivation was mainly to understand recent therapeutic,
pharmacological effects of neurosteroid administration (Gunduz-
Bruce et al., 2019). 3α5αP is also an endogenous neurosteroid
that may contribute to ongoing inhibitory tone. Estimates
of endogenous concentrations vary, but non-pregnancy
neurosteroid levels likely reach 30–70 nM in humans (Bixo
et al., 1997). We cannot exclude the possibility that these
concentrations of neurosteroid contributed to the “baseline”
IPSC and tonic-current profiles in our studies.
Our data indicate that the steroid-generated current
was mediated approximately equally by δ receptors and γ2
receptors. Our previous results suggest that at saturating GABA
concentrations, δ receptor current in DGCs is only 10–15%
of total current (Sun et al., 2018). Thus, 50% contribution to
neurosteroid-generated tonic current could reflect preference
for δ receptors. However, because Pbt quantitatively mimicked
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 January 2020 | Volume 13 | Article 6
fnmol-13-00006 January 20, 2020 Time: 17:14 # 10
Lu et al. Neurosteroid Selectivity at GABAA Receptors
the effect of steroids, we propose that the outsized effect of
neurosteroid on δ receptors is likely the result of the higher GABA
affinity of δ receptors compared with γ2 receptors rather than
true selectivity of δ receptors for neurosteroid or Pbt (Brown
et al., 2002; Wohlfarth et al., 2002). The low ambient GABA
concentration will preferentially recruit δ receptors, and active
receptors are more strongly affected by the positive allosteric
effects of the steroid (Brown et al., 2002; Wohlfarth et al., 2002).
Although we found that 100 nM 3α5αP was necessary
to reliably potentiate both phasic and tonic inhibition
(Figures 1–3), a previous study showed that as little as 10 nM
THDOC generated selective δ receptor effects, with higher
concentrations exhibiting less selectivity (Stell et al., 2003).
However, another study showed δ selectivity of 3α5αP up
to 1 µM (Carver and Reddy, 2016), and still another found
increased selectivity of δ receptor effects up to 10 µM of the
synthetic neurosteroid alphaxalone (Spigelman et al., 2003).
Thus, selectivity has been observed over a wide range of
concentrations. Behavioral results have suggested that anesthetic
and anxiolytic effects of neurosteroids are reduced in δ-deficient
animals (Mihalek et al., 1999). By contrast with these studies,
our results, using a different approach, support the idea that
at moderate concentrations, neurosteroids do not preferentially
target δ receptors.
Neurosteroids and ethanol share a proposed direct link, which
was the motivation for us to examine ethanol as a GABAA
receptor modulator. GABAA δ receptors may act as a sensor of
low concentrations of ethanol (Wallner et al., 2003; Wei et al.,
2004; Olsen et al., 2007), and at least some of ethanol’s effects
on GABAA receptors are proposed to occur through altered
neurosteroid synthesis (Sanna et al., 2004; Tokuda et al., 2011),
offering an explanation for δ selectivity. Although some results
have disputed the δ selectivity of ethanol (Borghese et al., 2006;
Yamashita et al., 2006; Fleming et al., 2011), we hypothesized that
δ∗ and γ2∗ mice would provide new tools to revisit this issue.
Our results failed to reveal significant potentiation of GABAA
mediated tonic current in DGCs, so at least in this cell type under
our conditions, the results do not allow us to comment on the
selectivity of ethanol or on ethanol-induced steroidogenesis for
δ receptors.
In summary, we have used genetic, pharmacological, and
electrophysiological approaches to investigate the selectivity
of neurosteroids on GABAA receptors. The sensitivity of our
approach supports a broad spectrum action of neurosteroids.
Recently, 3α5αP and another neuroactive steroid, SGE-217,
have been shown to have antidepressant effects (Kanes et al.,
2017; Gunduz-Bruce et al., 2019) and 3α5αP (brexanolone)
was approved for treatment of postpartum depression by the
Food and Drug Administration. Our work here suggests that δ
selectivity is unlikely to underlie the benefit. Other targets for
neurosteroids likely remain to be discovered that differ from
other GABAA receptor modulators, such as barbiturates and
benzodiazepines, to account for antidepressant benefit.
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